The Massachusetts Medical Society has shifted from a neutral stance on the pending patient supported Lyme legislation which would require insurers to cover longer-term Lyme treatment to one of opposing the bill. The House passed version is supported by Lyme groups, including the LDA, which supplied testimony is support of the precursor to these current bills Click Here LDA Testimony.
The letter from the Massachusetts Lyme Legislative Task Force clearly delineates the issues surrounding House FY17 Amendment # 729, H 4198 and S 2231 (all have identical wording) and why it is imperative for the legislature to pass them.
The LDA and the MA Task Force do not support the Senate FY17 Amendment #427. Click Here for MA Leg Task Force Letter